Article révisé par les pairs
Titre:
  • Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Auteur:Maher, Toby TM; Ford, Paul; Brown, Kevin K; Costabel, Ulrich; Cottin, Vincent; Danoff, Sonye SK; Groenveld, Irene; Helmer, Eric; Jenkins, R Gisli; Milner, J; Molenberghs, Geert; Penninckx, Bjorn; Randall, Matthew MJ; Van Den Blink, Bernt; Fieuw, Ann; Vandenrijn, Charlotte; Rocak, Sanda; Seghers, Ineke; Shao, Lixin; Taneja, Amit; Jentsch, Garrit; Watkins, Timothy R; Wuyts, Wim; Kreuter, Michael; Verbruggen, Nadia; Prasad, Niyati; Wijsenbeek, Marlies S; Bondue, Benjamin
Informations sur la publication:JAMA (Chicago, Ill.), 329, 18, page (1567-1578)
Statut de publication:Publié, 2023-05-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Aged
Humans
Male
Idiopathic Pulmonary Fibrosis -- drug therapy -- physiopathology
Lung -- drug effects -- physiopathology
Quality of Life
Randomized Controlled Trials as Topic
Respiratory Physiological Phenomena -- drug effects
Treatment Outcome
Clinical Trials, Phase III as Topic
Multicenter Studies as Topic
Administration, Oral
Middle Aged
Female
Phosphodiesterase Inhibitors -- pharmacology -- therapeutic use
Respiratory System Agents -- pharmacology -- therapeutic use
Langue:Anglais
Identificateurs:urn:issn:0098-7484
info:doi/10.1001/jama.2023.5355
info:pii/2804605
info:pmid/37159034
PMC10170340

Documents en relation

DI-fusion